Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
about
Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formationCurcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centuryNeuroprotection by spice-derived nutraceuticals: you are what you eat!Nutraceuticals in Parkinson's DiseasePlant-derived neuroprotective agents in Parkinson's diseaseAdvances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson's diseaseModulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanismsAdaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous systemMultifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregatesCurcumin's neuroprotective efficacy in Drosophila model of idiopathic Parkinson's disease is phase specific: implication of its therapeutic effectiveness.Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease.Characterization of polyethylene glycol-polyethyleneimine as a vector for alpha-synuclein siRNA delivery to PC12 cells for Parkinson's disease.Neuroprotection and sensorimotor functional improvement by curcumin after intracerebral hemorrhage in miceCurcumin Treatment Improves Motor Behavior in α-Synuclein Transgenic MiceTDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis.Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseasesCurcumin Protects against 1-Methyl-4-phenylpyridinium Ion- and Lipopolysaccharide-Induced Cytotoxicities in the Mouse Mesencephalic Astrocyte via Inhibiting the Cytochrome P450 2E1.Mitochondrial metals as a potential therapeutic target in neurodegeneration.Molecular chaperones and associated cellular clearance mechanisms against toxic protein conformers in Parkinson's disease.Multifaceted roles of curcumin: two sides of a coin!Curcumin and neurodegenerative diseases: a perspective.Copper as a key regulator of cell signalling pathways.Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy.Structural, morphological, and functional diversity of amyloid oligomers.α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.Curcumin Rescues a PINK1 Knock Down SH-SY5Y Cellular Model of Parkinson's Disease from Mitochondrial Dysfunction and Cell Death.Investigating dynamic structural and mechanical changes of neuroblastoma cells associated with glutamate-mediated neurodegeneration.α-Synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson's disease.Atomic force microscopy as an advanced tool in neuroscience.Small molecules interacting with α-synuclein: antiaggregating and cytoprotective properties.Indian Herbs for the Treatment of Neurodegenerative Disease.Curcumin modulates α-synuclein aggregation and toxicity.Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy.Effect of curcumin on lifespan, activity pattern, oxidative stress, and apoptosis in the brains of transgenic Drosophila model of Parkinson's disease.Curcumin inhibits apoptosis by regulating intracellular calcium release, reactive oxygen species and mitochondrial depolarization levels in SH-SY5Y neuronal cells.Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple MechanismsCurcumin modulates cell death and is protective in Huntington's disease model.A sensitive phage-based capture ELISA for sub-femtomolar detection of protein variants directly from biological samples.Synthesis of alginate-curcumin nanocomposite and its protective role in transgenic Drosophila model of Parkinson's diseaseAlpha-synuclein oligomers: a new hope.
P2860
Q24311960-FEBEE95E-A0EF-4F14-ADE7-77494B2A3013Q24630927-CED98F3B-61D5-4095-AC75-D5FB0DE8C239Q24635358-E88C99CD-73C2-4BFE-A0C7-2C65955077AEQ26752769-24B5D8F1-2CD4-4681-B20A-B22FCB85EC2BQ26795546-EC787F99-C539-4977-AB9D-E7C8B18B526AQ27023467-D0634131-8A0B-42C4-B39C-F033FBE94E60Q28259424-2184DB3E-4833-436C-9418-88A23B670EEBQ28389419-609A27A3-2608-4220-862D-E2BD2232FEFDQ34074933-EA23AFD8-9AC5-436F-B82D-72CDE513070EQ34729680-8AF35914-FA54-41E9-A4EC-CBF96A3B8F69Q34983243-02C0B222-269E-4FAF-9721-3DDD2C56D2B8Q35054395-39790118-3E8A-4065-89E1-04FEB981A773Q35606190-633E6CFF-3C64-4522-BE31-AF9A97689782Q35650069-106590E7-B717-44EE-ADC7-A6662910C8E6Q36260146-000924FF-AB68-4BC0-8C64-F5332821A937Q36479597-64B8CE3A-4E94-4944-89E6-FCBED1DAEB39Q36988551-A0219110-E024-4741-9467-E1592A5A7FD6Q37686294-BCC8EE9B-06E6-4874-986F-87DBA36558F0Q37853789-8D0F6D95-CD74-4234-A419-E2CFF5346055Q37937617-4E38EE66-49D0-4BD5-8267-9B946C670751Q38016212-389FD0A2-62F8-4984-9275-7B257A649737Q38213536-3723DAF6-2F50-4BE7-98C8-B47C30673358Q38213838-54366CC3-5789-4DB8-8A8F-422E72F75BE4Q38549882-44655E3C-88E1-4390-8B40-E9315139CAC4Q38669019-D721DC00-FFCA-4D9B-B9A4-9E25E6974B47Q38784071-09ACB7A1-2101-4C21-B302-6013CF55A7DAQ38940235-22A42FA1-BF28-4AF6-B5F9-13E3835E3283Q38947516-25948B0E-2C11-4C29-81DD-B611AEE082FAQ38998492-030996AF-4950-4EE5-A3DC-83006C3BAD1FQ39156104-539790CD-FE3F-44F6-815F-FBE3E18DDCBAQ39167139-EAF3328C-E987-49D9-AFDF-7AFEE8245514Q39178579-EA1CB3ED-A6C7-4F95-A76B-3A751F736A15Q39209459-06D401DE-B8C0-4850-B218-CC1657AC8CEAQ39467871-016E44B6-DB35-4A64-9230-63E86556F897Q40273636-33682791-BA7F-4116-A6C3-F616502B54A5Q41622472-37C0C5E3-A0B4-4A01-AD4E-CEF67A61BCC6Q41814213-6E980A83-7248-4BBE-94F8-7E61674BFCEBQ42190840-DD417F45-25E1-4E2F-87B7-916B931941AEQ42655220-868E49BB-6D7B-4BFF-88C2-2310971D891EQ46321755-63B5920F-D23A-4145-BA87-5FAD46C37169
P2860
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
@ast
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
@en
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
@nl
type
label
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
@ast
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
@en
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
@nl
prefLabel
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
@ast
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
@en
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
@nl
P2093
P2860
P921
P356
P1433
P1476
Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model.
@en
P2093
Michael R Sierks
Shanta Boddapati
Sharareh Emadi
P2860
P2888
P356
10.1186/1471-2202-11-57
P50
P577
2010-04-30T00:00:00Z
P5875
P6179
1023043810